UroGen Pharma Ltd. (URGN)

SEC filing

UroGen Pharma Ltd.

URGN · CIK 1668243

4 · Sep 9, 2026 · General Counsel Smith Jason Drew sold 1,519 shares at $42.54/share ($64,618); exercised options for 3,334 shares

General Counsel Smith Jason Drew sold 1,519 shares at $42.54/share ($64,618); exercised options for 3,334 shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).